Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $8,281 - $9,035
112 Added 1.41%
8,030 $601,000
Q2 2023

Aug 02, 2023

SELL
$76.01 - $86.7 $18,546 - $21,154
-244 Reduced 2.99%
7,918 $610,000
Q1 2023

Apr 18, 2023

BUY
$77.31 - $88.08 $11,209 - $12,771
145 Added 1.81%
8,162 $677,000
Q4 2022

Jan 26, 2023

BUY
$62.32 - $89.47 $41,754 - $59,944
670 Added 9.12%
8,017 $0
Q3 2022

Oct 17, 2022

BUY
$59.54 - $68.01 $10,895 - $12,445
183 Added 2.55%
7,347 $453,000
Q2 2022

Jul 12, 2022

BUY
$57.72 - $65.01 $113,997 - $128,394
1,975 Added 38.06%
7,164 $443,000
Q1 2022

Apr 18, 2022

BUY
$57.92 - $72.58 $17,028 - $21,338
294 Added 6.01%
5,189 $310,000
Q4 2021

Jan 20, 2022

BUY
$64.88 - $73.64 $14,468 - $16,421
223 Added 4.77%
4,895 $355,000
Q3 2021

Oct 14, 2021

BUY
$67.69 - $73.03 $19,765 - $21,324
292 Added 6.67%
4,672 $326,000
Q2 2021

Jul 23, 2021

BUY
$63.47 - $69.35 $27,228 - $29,751
429 Added 10.86%
4,380 $302,000
Q1 2021

Apr 26, 2021

SELL
$60.0 - $68.46 $400,260 - $456,696
-6,671 Reduced 62.8%
3,951 $260,000
Q4 2020

Jan 19, 2021

BUY
$56.65 - $64.55 $15,408 - $17,557
272 Added 2.63%
10,622 $670,000
Q3 2020

Oct 19, 2020

BUY
$62.1 - $78.08 $27,199 - $34,199
438 Added 4.42%
10,350 $654,000
Q2 2020

Jul 24, 2020

BUY
$72.34 - $84.0 $10,778 - $12,516
149 Added 1.53%
9,912 $763,000
Q1 2020

Apr 29, 2020

BUY
$62.63 - $80.22 $611,456 - $783,187
9,763 New
9,763 $730,000
Q3 2019

Oct 23, 2019

SELL
$62.51 - $69.0 $81,263 - $89,700
-1,300 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $10,594 - $13,825
-175 Reduced 11.86%
1,300 $81,000
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $107,439 - $130,980
1,475 New
1,475 $106,000
Q4 2017

Feb 16, 2018

SELL
$71.15 - $83.52 $293,493 - $344,520
-4,125 Closed
0 $0
Q3 2017

Nov 17, 2017

BUY
$72.11 - $85.47 $292,045 - $346,153
4,050 Added 5400.0%
4,125 $334,000
Q2 2017

Aug 18, 2017

BUY
N/A
75
75 $3,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.